Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies

Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies November 2018, Article on Genomeweb.com Get the PDF file Stilla Technologies announced today that it has completed a €16 million ($18.3 million) Series A financing round led by Illumina Ventures. Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay [...]

2018-11-21T10:36:16+01:00November 21st, 2018|Press releases|

Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification

Paris-based Stilla Technologies has raised €16M in a Series A round November 2018, Article on Labiotech.eu Get the PDF file Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification with promising applications in diagnostics. The round was led by [...]

2018-11-21T10:30:35+01:00November 21st, 2018|Press releases|

Stilla Technologies completes €16 Million ($18 Million) Series A

November 20th, 2018 Stilla Technologies completes €16 Million Series A  Illumina Ventures led the financing round Objective: financing to commercialize its novel digital PCR system and develop clinical applications. Paris, November 20th, 2018. Stilla Technologies, the European provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion [...]

2018-11-20T12:27:24+01:00November 20th, 2018|Press releases|